Guido Beldi

Dr. Guido Beldi

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MDMichel Ernest Jean-Pierre Dosch
Michel Ernest Jean-Pierre Dosch
JGJoël Gerber
Joël Gerber
FJFadi Jebbawi
Fadi Jebbawi
GBGuido Beldi
Guido Beldi
Extracellular nucleotides (e.g., ATP, ADP, UTP, UDP) released by inflammatory cells interact with specific purinergic P2 type receptors to modulate their recruitment and activation. The focus of this review is on stimuli and mechanisms of extracellular nucleotide release and its consequences during inflammation. Necrosis leads to non-specific release of nucleotides, whereas specific release mechanisms include vesicular exocytosis and channel-mediated release via connexin or pannexin hemichannels. These release mechanisms allow stimulated inflammatory cells such as macrophages, neutrophils, and endothelial cells to fine-tune autocrine/paracrine responses during acute and chronic inflammation. Key effector functions of inflammatory cells are therefore regulated by purinergic signaling in acute and chronic diseases, making extracellular nucleotide release a promising target for the development of new therapies.

15 April 2008 in Cancer Research
Verified
Journal Article
Open access
PDF file
ZDZoltan Derdak
Zoltan Derdak
NMNicholas M. Mark
Nicholas M. Mark
GBGuido Beldi
Guido Beldi
SRSimon C. Robson
Simon C. Robson
JWJack R. Wands
Jack R. Wands
GBGyorgy Baffy
Gyorgy Baffy
Cancer cells acquire drug resistance as a result of selection pressure dictated by unfavorable microenvironments. This survival process is facilitated through efficient control of oxidative stress originating from mitochondria that typically initiates programmed cell death. We show this critical adaptive response in cancer cells to be linked to uncoupling protein-2 (UCP2), a mitochondrial suppressor of reactive oxygen species (ROS). UCP2 is present in drug-resistant lines of various cancer cells and in human colon cancer. Overexpression of UCP2 in HCT116 human colon cancer cells inhibits ROS accumulation and apoptosis after exposure to chemotherapeutic agents. Tumor xenografts of UCP2-overexpressing HCT116 cells retain growth in nude mice receiving chemotherapy. Augmented cancer cell survival is accompanied by altered NH2-terminal phosphorylation of the pivotal tumor suppressor p53 and induction of the glycolytic phenotype (Warburg effect). These findings link UCP2 with molecular mechanisms of chemoresistance. Targeting UCP2 may be considered a novel treatment strategy for cancer. [Cancer Res 2008;68(8):2813–9]

4 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JLJoël L. Lavanchy
Joël L. Lavanchy
JZJoel Zindel
Joel Zindel
KKKadir Kirtac
Kadir Kirtac
ITIsabell Twick
Isabell Twick
EHEnes Hosgor
Enes Hosgor
GBGuido Beldi
Guido Beldi
Surgical skills are associated with clinical outcomes. To improve surgical skills and thereby reduce adverse outcomes, continuous surgical training and feedback is required. Currently, assessment of surgical skills is a manual and time-consuming process which is prone to subjective interpretation. This study aims to automate surgical skill assessment in laparoscopic cholecystectomy videos using machine learning algorithms. To address this, a three-stage machine learning method is proposed: first, a Convolutional Neural Network was trained to identify and localize surgical instruments. Second, motion features were extracted from the detected instrument localizations throughout time. Third, a linear regression model was trained based on the extracted motion features to predict surgical skills. This three-stage modeling approach achieved an accuracy of 87 ± 0.2% in distinguishing good versus poor surgical skill. While the technique cannot reliably quantify the degree of surgical skill yet it represents an important advance towards automation of surgical skill assessment.

19 May 2004 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
GBGuido Beldi
Guido Beldi
TKThomas Kinsbergen
Thomas Kinsbergen
RSRolf Schlumpf
Rolf Schlumpf

1 August 2009 in The American Journal of Surgery
Verified
Journal Article
Closed access
GBGuido Beldi
Guido Beldi
SBSonja Bisch-Knaden
Sonja Bisch-Knaden
VBVanessa Banz
Vanessa Banz
KMKathrin Mühlemann
Kathrin Mühlemann
DCDaniel Candinas
Daniel Candinas

1 October 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RCRoss Corriden
Ross Corriden
YCYu Chen
Yu Chen
YIYoshiaki Inoue
Yoshiaki Inoue
GBGuido Beldi
Guido Beldi
SRSimon C. Robson
Simon C. Robson
WJWolfgang G. Junger
Wolfgang G. Junger
Polymorphonuclear neutrophils release ATP in response to stimulation by chemoattractants, such as the peptide N-formyl-methionyl-leucyl-phenylalanine. Released ATP and the hydrolytic product adenosine regulate chemotaxis of neutrophils by sequentially activating purinergic nucleotide and adenosine receptors, respectively. Here we show that that ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1, CD39) is a critical enzyme for hydrolysis of released ATP by neutrophils and for cell migration in response to multiple agonists (N-formyl-methionyl-leucyl-phenylalanine, interleukin-8, and C5a). Upon stimulation of human neutrophils or differentiated HL-60 cells in a chemotactic gradient, E-NTPDase1 tightly associates with the leading edge of polarized cells during chemotaxis. Inhibition of E-NTPDase1 reduces the migration speed of neutrophils but not their ability to detect the orientation of the gradient field. Studies of neutrophils from E-NTPDase1 knock-out mice reveal similar impairments of chemotaxis in vitro and in vivo. Thus, E-NTPDase1 plays an important role in regulating neutrophil chemotaxis by facilitating the hydrolysis of extracellular ATP.